Crispr Therapeutics AG (CRSP) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Crispr Therapeutics AG (CRSP) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Crispr Therapeutics AG

· CRSP

Dashboard

Financials

KPIs

Ratios

Valuation

Statistics

5.415 B

-1.21%

General

Market Cap: $5.41B
Enterprise Value: $5.83B
Shares Outstanding: 96,450,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: -1534.39%
Operating Margin: -3971.53%
Net Profit Margin: -3368.72%
FCF Margin: -3589.65%
ROA: -17.02%
ROE: -24.39%
ROIC: -20.97%
Current Ratio: 17.85
Debt-to-Equity: 0.45
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 398.41
P/FCF: —
P/B: 3.05
EV/EBITDA: -12.84

Growth

Rev 1Y: -89.97%
Rev 1Y Fwd Est: 944.92%
Rev 3Y (CAGR): 100.42%
Rev 5Y (CAGR): 37.31%
Rev 10Y (CAGR): 30.40%
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $13.39M
Gross Margin: -1534.39%
Operating Expenses: $326.38M
Operating Income: -$531.87M
Net Profit: -$451.14M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $291.34M
Working Capital: $2.24B
Total Assets: $2.65B
Net Debt: $492.41M
Total Liabilities: $904.22M
Total Equity: $1.75B

Cash Flow Statement (TTM)

Cash Flow from Operations: -$478.48M
Cash Flow from Investing: -$959.17M
Cash Flow from Financing: $1.6B
Free Cash Flow: -$480.73M
Capital Expenditures: $2.25M